Your browser doesn't support javascript.
Guillain-Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain-Barré syndrome.
Ling, Ling; Bagshaw, Sean M; Villeneuve, Pierre-Marc.
  • Ling L; Department of Medicine, Faculty of Medicine and Dentistry (Ling, Bagshaw), University of Alberta and Alberta Health Services; Department of Critical Care and Medicine, Division of Internal Medicine (Villeneuve), University of Alberta and Grey Nuns Hospitals, Edmonton, Alta.
  • Bagshaw SM; Department of Medicine, Faculty of Medicine and Dentistry (Ling, Bagshaw), University of Alberta and Alberta Health Services; Department of Critical Care and Medicine, Division of Internal Medicine (Villeneuve), University of Alberta and Grey Nuns Hospitals, Edmonton, Alta.
  • Villeneuve PM; Department of Medicine, Faculty of Medicine and Dentistry (Ling, Bagshaw), University of Alberta and Alberta Health Services; Department of Critical Care and Medicine, Division of Internal Medicine (Villeneuve), University of Alberta and Grey Nuns Hospitals, Edmonton, Alta. pierremarc.villeneuve@albertahealthservices.ca.
CMAJ ; 193(46): E1766-E1769, 2021 11 22.
Article in English | MEDLINE | ID: covidwho-1528742

Full text: Available Collection: International databases Database: MEDLINE Main subject: Guillain-Barre Syndrome / COVID-19 / ChAdOx1 nCoV-19 Type of study: Case report Topics: Vaccines Limits: Humans / Male / Middle aged Language: English Journal: CMAJ Journal subject: Medicine Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Guillain-Barre Syndrome / COVID-19 / ChAdOx1 nCoV-19 Type of study: Case report Topics: Vaccines Limits: Humans / Male / Middle aged Language: English Journal: CMAJ Journal subject: Medicine Year: 2021 Document Type: Article